💊 Thuốc A-Z 🧬 Đích tác dụng 🛠 Công cụ 📚 Hướng dẫn
Tất cả thuốc Phân loại thuốc Lĩnh vực điều trị Tác dụng phụ
Hướng dẫn Từ điển thuật ngữ Dòng thời gian
So sánh Hành trình của thuốc Các họ thuốc
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

Sodium Pertechnetate

CHEMBL2110571 Phase 4 Đã phê duyệt Small molecule
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
183.9 g/mol
LogP
—
Phase
4

Sodium pertechnetate is an inorganic technetium salt used as a general-purpose radiopharmaceutical precursor and diagnostic imaging agent for thyroid scintigraphy, Meckel's diverticulum scanning, and radionuclide ventriculography in prostate cancer and rheumatoid arthritis assessment. As the pertechnetate anion (TcO4-), it is a chemical analog of iodide and is concentrated by the thyroid gland and gastric mucosa via the sodium-iodide symporter. It is the primary precursor for labeling other technetium-99m radiopharmaceuticals.

Khối lượng phân tử

183,8940 g/mol

TPSA

74,30 Ų

Lĩnh vực điều trị

Thyroid Cancer Rheumatoid Arthritis Prostate Cancer

Cơ chế tác dụng

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cơ chế

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

SMILES

[O-][Tc](=O)(=O)=O.[Na+]

InChI

InChI=1S/Na.4O.Tc/q+1;;;;-1;

Molecular Formula

NaO4Tc

HBD / HBA

- / 4

Liên kết có thể quay

0

Nguyên tử nặng

6

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

Sodium pertechnetate is an inorganic technetium salt used as a general-purpose radiopharmaceutical precursor and diagnostic imaging agent for thyroid scintigraphy, Meckel's diverticulum scanning, and radionuclide ventriculography in prostate cancer and rheumatoid arthritis assessment. As the pertechnetate anion (TcO4-), it is a chemical analog of iodide and is concentrated by the thyroid gland and gastric mucosa via the sodium-iodide symporter. It is the primary precursor for labeling other technetium-99m radiopharmaceuticals.

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Yes, Sodium Pertechnetate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2110571. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 74086836. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.